Acadia Pharma Q2 2024 Earnings Preview

by
Contributor since / Followers
1 month ago
  • Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q2 earnings results on Tuesday, August 6th, after market close.
  • The consensus EPS Estimate is $0.18 and the consensus Revenue Estimate is $235.66M (+42.6% Y/Y).
  • Over the last 3 months, EPS estimates have seen
Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *